Rok IPO společnosti Apellis Pharmaceuticals Inc

Jaká je hodnota metriky Rok IPO společnosti Apellis Pharmaceuticals Inc?

Hodnota metriky Rok IPO společnosti Apellis Pharmaceuticals Inc je 1970

Jaká je definice metriky Rok IPO?

IPO je rok počáteční veřejné nabídky akcií společnosti, kdy se akcie společnosti začnou veřejně obchodovat.

Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.

Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.

The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.

Rok IPO společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Apellis Pharmaceuticals Inc

Čemu se věnuje společnost Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Firmy s metrikou rok ipo podobnou společnosti Apellis Pharmaceuticals Inc